ArticleCardiovascular therapeutics2025
Association Between Blood Cadmium Levels and Heart Failure Risk: Insights From NHANES 2009-2014.
Article in Cardiovascular therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heart failure (HF) is a major global public health problem, and identifying modifiable environmental risk factors is important for prevention. We evaluated the association between blood cadmium levels and the risk of HF in US adults. Methods: We analyzed data from the National Health and Nutrition Examination Survey (NHANES) 2009-2014. A total of 10,542 adults with complete information on blood cadmium and HF status were included. Weighted multivariable logistic regression models were used to assess the relationship between blood cadmium and self-reported HF. Restricted cubic spline (RCS) regression and two-piecewise linear models were applied to explore potential dose-response relationships. Results: A cohort of 10,542 US adults from the NHANES 2009-2014 dataset was analyzed, including 321 individuals diagnosed with HF. In fully adjusted, weighted logistic regression models, elevated blood cadmium levels were significantly correlated with an increased prevalence of HF. Specifically, each 1 Conclusions: Elevated blood cadmium is an independent risk factor for HF in the United States. These findings suggest that reducing cadmium exposure may be a novel strategy for HF prevention. Prospective studies are warranted to clarify causal relationships and underlying mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.